Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Nishida

Showing results (61-70 of 164) with videos related to

Pageof 17
Sort By:
BMJ Open|December 5, 2020
Randomised controlled trial of conditioning regimen for cord blood transplantation for adult myeloid malignancies comparing high-dose cytarabine/cyclophosphamide/total body irradiation with versus without G-CSF priming: G-CONCORD study protocolSeitaro Terakura, Takaaki Konuma, Masatsugu Tanaka, et al.
Transplantation and Cellular Therapy|May 2, 2024
Impact of Early Cytomegalovirus Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation on Relapse in Patients With Myelodysplastic Syndrome: A Nationwide Retrospective Study From Adult Myelodysplastic Syndrome Working Group of the JSTCTTatsuya Konishi, Kensuke Matsuda, Hidehiro Itonaga, et al.
International Journal of Hematology|January 17, 2025
Post-transplant TKIs for Ph+ ALL: practices to date and clinical significanceSatoshi Nishiwaki, Seitaro Terakura, Takanobu Morishita, et al.
Vox Sanguinis|March 1, 2024
RhD mismatch does not affect haematopoietic recovery, graft-versus-host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry-based studyTakaaki Konuma, Naoyuki Uchida, Wataru Takeda, et al.
Stem Cells Translational Medicine|December 14, 2020
Phase I clinical trial of intra-bone marrow cotransplantation of mesenchymal stem cells in cord blood transplantationTatsunori Goto, Makoto Murata, Tetsuya Nishida, et al.
International Journal of Hematology|August 10, 2023
Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterpartsErina Takagi, Seitaro Terakura, Hidetsugu Fujigaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2014
Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cellsKeisuke Watanabe, Seitaro Terakura, Anton C Martens, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2021
Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survivalJakrawadee Julamanee, Seitaro Terakura, Koji Umemura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working GroupKatsuto Takenaka, Tetsuya Nishida, Yuki Asano-Mori, et al.
American Journal of Hematology|November 15, 2023
Hematopoietic stem cell transplantation from haploidentical offspring donors using post-transplant cyclophosphamide versus human leukocyte antigen-matched siblings in older patients with myelodysplastic syndromeYoshimitsu Shimomura, Tetsuhisa Kitamura, Takaaki Konuma, et al.
Pageof 17

Showing results (61-70 of 164) with videos related to

Sort By:
Pageof 17
BMJ Open|December 5, 2020
Randomised controlled trial of conditioning regimen for cord blood transplantation for adult myeloid malignancies comparing high-dose cytarabine/cyclophosphamide/total body irradiation with versus without G-CSF priming: G-CONCORD study protocolSeitaro Terakura, Takaaki Konuma, Masatsugu Tanaka, et al.
Transplantation and Cellular Therapy|May 2, 2024
Impact of Early Cytomegalovirus Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation on Relapse in Patients With Myelodysplastic Syndrome: A Nationwide Retrospective Study From Adult Myelodysplastic Syndrome Working Group of the JSTCTTatsuya Konishi, Kensuke Matsuda, Hidehiro Itonaga, et al.
International Journal of Hematology|January 17, 2025
Post-transplant TKIs for Ph+ ALL: practices to date and clinical significanceSatoshi Nishiwaki, Seitaro Terakura, Takanobu Morishita, et al.
Vox Sanguinis|March 1, 2024
RhD mismatch does not affect haematopoietic recovery, graft-versus-host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry-based studyTakaaki Konuma, Naoyuki Uchida, Wataru Takeda, et al.
Stem Cells Translational Medicine|December 14, 2020
Phase I clinical trial of intra-bone marrow cotransplantation of mesenchymal stem cells in cord blood transplantationTatsunori Goto, Makoto Murata, Tetsuya Nishida, et al.
International Journal of Hematology|August 10, 2023
Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterpartsErina Takagi, Seitaro Terakura, Hidetsugu Fujigaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2014
Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cellsKeisuke Watanabe, Seitaro Terakura, Anton C Martens, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2021
Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survivalJakrawadee Julamanee, Seitaro Terakura, Koji Umemura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working GroupKatsuto Takenaka, Tetsuya Nishida, Yuki Asano-Mori, et al.
American Journal of Hematology|November 15, 2023
Hematopoietic stem cell transplantation from haploidentical offspring donors using post-transplant cyclophosphamide versus human leukocyte antigen-matched siblings in older patients with myelodysplastic syndromeYoshimitsu Shimomura, Tetsuhisa Kitamura, Takaaki Konuma, et al.
Pageof 17